{"id":"https://genegraph.clinicalgenome.org/r/78de7402-400d-4c0f-96ba-6ae9c4b1badav1.0","type":"EvidenceStrengthAssertion","dc:description":"PNPO was first reported in relation to autosomal recessive pyridoxal phosphate-responsive seizures in 2005 (Mills et al., 2005, PMID: 15772097). Pyridoxal phosphate-responsive seizures (MONDO: 0012407) is characterized by neonatal-onset severe seizures commonly observed within the first several hours to days of life, and subsequent encephalopathy. Developmental delay, intellectual disability, hypotonia, erratic eye movements, etc are also observed in patients with variants in PNPO. Fourteen variants (missense and frameshift) that have been reported in twenty-six probands in nine publications (PMIDs: 15772097, 23430561, 18485777, 24266778, 24658933, 24645144, 25296925, 28133863, 28985901) are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. This gene-disease association is also supported by animal models and a rescue (PMIDs: 15772097, 31261385, 31616300, 31759955). Chi et al., 2019 (PMID: 31261385) demonstrated cell-type specific expression in sugarlethal drosophila with the previously identified variant c.95C>A is a valid model for PNPO-deficiency induced epilepsy. Ciapaite et al., 2020 (PMID: 31759955) used CRISPR/Cas9 gene editing to generate Pnpo-deficient zebrafish in which locomotion analysis demonstrated that these zebrafish developed seizures and only 38% survived. Even though the default points for animal models is 2 points, the ClinGen Epilepsy GCEP has decided to downgrade evidence in Chi et al., 2019 and Ciapaite et al., 2020 to 1 point because they are non-mammalian model systems. An additional line of experimental evidence (rescue) was published by Chen et al., 2019 (PMID: 31616300). In summary, PNPO is definitively associated with autosomal recessive pyridoxal phosphate-responsive seizures. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Epilepsy Gene Curation Expert Panel on 12/15/2020 (SOP Version 8).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/78de7402-400d-4c0f-96ba-6ae9c4b1bada","GCISnapshot":"https://genegraph.clinicalgenome.org/r/f3ff7b38-dd26-458a-afbb-4870785c42ec","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/f3ff7b38-dd26-458a-afbb-4870785c42ec_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10005","date":"2021-11-02T16:56:59.021Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/f3ff7b38-dd26-458a-afbb-4870785c42ec_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10005","date":"2020-12-15T17:00:00.000Z","role":"Approver"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f3ff7b38-dd26-458a-afbb-4870785c42ec_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f3ff7b38-dd26-458a-afbb-4870785c42ec_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ff8ebfb8-e3a9-467c-bb06-d64427e38975","type":"EvidenceLine","dc:description":"downgraded to 1 point because it is a zebrafish model without electrophysical correction","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/52c4aa3f-768d-4fdd-ac45-afc85e15d3e8","type":"Finding","dc:description":"locomotion analysis used to show pnpo-/- zebrafish developing sizures","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31759955","rdfs:label":"Pnpo deficient zebrafish","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/97965492-7f31-4788-b6f6-8d3ac18f47b8","type":"EvidenceLine","dc:description":"Downgraded to 1 point because it is a non-mammalian model system.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4f03ab76-bd82-4912-9dcb-d60ee79dbd46","type":"Finding","dc:description":"Both lethality are associated with low PLP levels and can be rescued by ubiquitous expression of wild-type sgll and hPNPO, suggesting functional conservation of PNPO between human and flies. Sgll95 homozygotes reared on sugar-only diet exhibit lethal phenotype (100%) vs wildtype (sgll95 5-day vs sgll KD 4-day survival). Cell-type specific expression sgll KD demonstrate PNPO in brain is necessary for seizure prevention/survival.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31261385","rdfs:label":"PNPO in Brain is Necessary for Seizure Prevention","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/d175da31-165b-47ee-bb64-ea0cef6971e5","type":"EvidenceLine","dc:description":"downgraded to 0 points because it is a vertebrate, non-mammalian and did not actually assess the phenotypes observed in humans with variants in PNPO and pyridoxal phosphate-responsive seizures","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/118cc404-7e49-4418-ad40-be8a83e0817b","type":"Finding","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31616300","rdfs:label":"Rescue with zpnpo and hPNPO mRNA","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityNonHumanRescueCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/f3ff7b38-dd26-458a-afbb-4870785c42ec_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d00b6375-515f-4d6a-801f-4587a8d8902f_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3d5583bf-4636-4435-be0e-5b6e59a52356","type":"EvidenceLine","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3d5583bf-4636-4435-be0e-5b6e59a52356_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28985901","allele":{"id":"https://genegraph.clinicalgenome.org/r/234ee2fd-54d0-448d-b690-d3798e8b2bff","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_018129.4(PNPO):c.674G>T (p.Arg225Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA316566"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/d00b6375-515f-4d6a-801f-4587a8d8902f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28985901","rdfs:label":"Guerriero Patient 5","allele":{"id":"https://genegraph.clinicalgenome.org/r/234ee2fd-54d0-448d-b690-d3798e8b2bff"},"detectionMethod":"Unknown testing strategy","phenotypeFreeText":"elevated alkaline phosphatase","phenotypes":["obo:HP_0200134","obo:HP_0012758","obo:HP_0001250"],"sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/3d5583bf-4636-4435-be0e-5b6e59a52356_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/40fc6103-7df8-47f8-95df-8b771b1d1bd0_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0a2e9cea-d87d-4507-ab5e-a1d4b1a71cf2","type":"EvidenceLine","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0a2e9cea-d87d-4507-ab5e-a1d4b1a71cf2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23430561","allele":{"id":"https://genegraph.clinicalgenome.org/r/ad571250-0016-4652-a326-c474cf15d560","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_018129.4(PNPO):c.352G>A (p.Gly118Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA400057365"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/40fc6103-7df8-47f8-95df-8b771b1d1bd0","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23430561","rdfs:label":"Male","allele":{"id":"https://genegraph.clinicalgenome.org/r/ad571250-0016-4652-a326-c474cf15d560"},"detectionMethod":"PNPO Targeted sequencing","firstTestingMethod":"Other","phenotypes":["obo:HP_0012758","obo:HP_0000737","obo:HP_0032807","obo:HP_0000496","obo:HP_0001252"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/0a2e9cea-d87d-4507-ab5e-a1d4b1a71cf2_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/18daf778-446a-46b1-b861-e878827a8cb7_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a6efc705-390c-4dc0-86ed-9dfa45de6f7b","type":"EvidenceLine","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a6efc705-390c-4dc0-86ed-9dfa45de6f7b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24645144","allele":{"id":"https://genegraph.clinicalgenome.org/r/046ccf56-9dfb-4a92-be8f-001eba725443","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_018129.4(PNPO):c.283C>T (p.Arg95Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/1297019"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/18daf778-446a-46b1-b861-e878827a8cb7","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24645144","rdfs:label":"Mills Patient 5","allele":{"id":"https://genegraph.clinicalgenome.org/r/046ccf56-9dfb-4a92-be8f-001eba725443"},"detectionMethod":"DNA analysis from the chorionic villus indicated that the foetus was affected","firstTestingMethod":"Other","phenotypeFreeText":"IQ 66 at 9 mo","phenotypes":["obo:HP_0008936","obo:HP_0001250","obo:HP_0000750"],"sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/a6efc705-390c-4dc0-86ed-9dfa45de6f7b_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/4a54fa3c-649f-4722-b3c1-363d0d62014f_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/14aca4fb-5794-4206-a2ac-a0e09277477a","type":"EvidenceLine","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/14aca4fb-5794-4206-a2ac-a0e09277477a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28985901","allele":{"id":"https://genegraph.clinicalgenome.org/r/234ee2fd-54d0-448d-b690-d3798e8b2bff"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/4a54fa3c-649f-4722-b3c1-363d0d62014f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28985901","rdfs:label":"Guerriero Patient 3","allele":{"id":"https://genegraph.clinicalgenome.org/r/234ee2fd-54d0-448d-b690-d3798e8b2bff"},"detectionMethod":"Unknown testing strategy","phenotypes":["obo:HP_0001250","obo:HP_0012758","obo:HP_0200134"],"sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/14aca4fb-5794-4206-a2ac-a0e09277477a_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/403c29e4-684e-4048-b622-7888eba6b01f_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cfde8988-0b31-457b-92bd-57d1f8d41ade","type":"EvidenceLine","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cfde8988-0b31-457b-92bd-57d1f8d41ade_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24266778","allele":{"id":"https://genegraph.clinicalgenome.org/r/778540fe-d8c9-4040-827f-d01dd813d406","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_018129.4(PNPO):c.686G>A (p.Arg229Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA316568"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/403c29e4-684e-4048-b622-7888eba6b01f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24266778","rdfs:label":"Case 2","ageType":"AgeAtOnset","ageUnit":"Days","ageValue":1,"allele":{"id":"https://genegraph.clinicalgenome.org/r/778540fe-d8c9-4040-827f-d01dd813d406"},"detectionMethod":"SNP array followed by single gene test for PNPO","ethnicity":{"id":"cg:NotHispanicOrLatino"},"phenotypes":["obo:HP_0000496","obo:HP_0032816","obo:HP_0032794"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/cfde8988-0b31-457b-92bd-57d1f8d41ade_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/ff2086aa-7e7d-4291-8e5f-65664a2cbe7a_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c41fe1ad-8739-4d38-9d47-d40080ec0ca9","type":"EvidenceLine","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c41fe1ad-8739-4d38-9d47-d40080ec0ca9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28985901","allele":{"id":"https://genegraph.clinicalgenome.org/r/778540fe-d8c9-4040-827f-d01dd813d406"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/ff2086aa-7e7d-4291-8e5f-65664a2cbe7a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28985901","rdfs:label":"Guerriero Patient 1","allele":{"id":"https://genegraph.clinicalgenome.org/r/778540fe-d8c9-4040-827f-d01dd813d406"},"detectionMethod":"Unknown testing strategy","phenotypeFreeText":"elevated alkaline phosphate","phenotypes":["obo:HP_0012758","obo:HP_0000488","obo:HP_0001250","obo:HP_0200134"],"sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/c41fe1ad-8739-4d38-9d47-d40080ec0ca9_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/2d481a9c-115f-4859-9003-0a7a0f23dc41_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5a549fa1-1d85-4e8b-b54e-fbeea5625531","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5a549fa1-1d85-4e8b-b54e-fbeea5625531_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Expression studies using transfected CHO cells showed undetectable enzyme activity for R225H; a reduction of activity by 51% for Arg141Cys and undetectable activity for p.Ala94_Leu97del.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/5a549fa1-1d85-4e8b-b54e-fbeea5625531_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24658933","allele":{"id":"https://genegraph.clinicalgenome.org/r/fdf2e1e3-53b5-44de-9d50-58f65c194c3c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_018129.4(PNPO):c.674G>A (p.Arg225His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA354181"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/2d481a9c-115f-4859-9003-0a7a0f23dc41","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24658933","rdfs:label":"Patient 5","allele":{"id":"https://genegraph.clinicalgenome.org/r/fdf2e1e3-53b5-44de-9d50-58f65c194c3c"},"detectionMethod":"ALDH7A1 normal sequence followed by single gene test for PNPO","firstTestingMethod":"Other","phenotypes":["obo:HP_0000496","obo:HP_0001336","obo:HP_0002317"],"sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/5a549fa1-1d85-4e8b-b54e-fbeea5625531_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/d5ad1230-cc75-4247-9f89-1cabd49d7263_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8a5726e2-24dd-4f28-8f70-1529c1f6903c","type":"EvidenceLine","dc:description":"Homozygous nonsense variant with functional data from 2 publications indicating a reduction of 100% (Mills et al, 2005) and 88% (Mills et al, 2014) in protein expression. The Epilepsy GCEP upgraded to 3 points total for increased evidence for pathogenicity. Additionally this proband has a affected sibling.","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8a5726e2-24dd-4f28-8f70-1529c1f6903c_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional data from 2 publications indicating a reduction of 100% (Mills et al, 2005) and 88% (Mills et al, 2014) in protein expression.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/8a5726e2-24dd-4f28-8f70-1529c1f6903c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15772097","allele":{"id":"https://genegraph.clinicalgenome.org/r/a0ad5b34-177e-4f57-9044-b4357602ea9c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_018129.4(PNPO):c.784T>C (p.Ter262Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA118330"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/d5ad1230-cc75-4247-9f89-1cabd49d7263","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15772097","rdfs:label":"Patient K1","ageType":"AgeAtOnset","ageUnit":"Days","ageValue":1,"allele":{"id":"https://genegraph.clinicalgenome.org/r/a0ad5b34-177e-4f57-9044-b4357602ea9c"},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/8a5726e2-24dd-4f28-8f70-1529c1f6903c_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/5310c1cb-532c-49e3-bc3a-b92578500c2d_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/544486e7-9335-4fe8-b2d2-222f06b4205c","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/544486e7-9335-4fe8-b2d2-222f06b4205c_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Expression studies using transfected CHO cells showed undetectable enzyme activity for R225H; a reduction of activity by 51% for Arg141Cys and undetectable activity for p.Ala94_Leu97del.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/544486e7-9335-4fe8-b2d2-222f06b4205c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24658933","allele":{"id":"https://genegraph.clinicalgenome.org/r/be367505-5d25-4379-b0da-b52ac7e48ad2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_018129.4(PNPO):c.421C>T (p.Arg141Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA8629191"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/1509df2a-7d63-4940-aa43-e3f4fab4cb20","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1509df2a-7d63-4940-aa43-e3f4fab4cb20_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Expression studies using transfected CHO cells showed undetectable enzyme activity for R225H; a reduction of activity by 51% for Arg141Cys and undetectable activity for p.Ala94_Leu97del.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/1509df2a-7d63-4940-aa43-e3f4fab4cb20_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24658933","allele":{"id":"https://genegraph.clinicalgenome.org/r/8e7f9b41-fcaf-43c8-a5e6-f436e075a1a3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_018129.4(PNPO):c.279_290del (p.Ala94_Leu97del)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2499214028"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/5310c1cb-532c-49e3-bc3a-b92578500c2d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24658933","rdfs:label":"Patient 3","allele":[{"id":"https://genegraph.clinicalgenome.org/r/8e7f9b41-fcaf-43c8-a5e6-f436e075a1a3"},{"id":"https://genegraph.clinicalgenome.org/r/be367505-5d25-4379-b0da-b52ac7e48ad2"}],"detectionMethod":"ALDH7A1 normal sequence followed by single gene test for PNPO","firstTestingMethod":"Other","phenotypes":["obo:HP_0000496","obo:HP_0002133","obo:HP_0001336"],"sex":"UnknownEthnicity","variant":[{"id":"https://genegraph.clinicalgenome.org/r/544486e7-9335-4fe8-b2d2-222f06b4205c_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/1509df2a-7d63-4940-aa43-e3f4fab4cb20_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/38edbd82-7008-4a6b-9243-7390ec4e3c98_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/36fd4390-4f3b-4adb-9b24-bbf077ce4050","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/36fd4390-4f3b-4adb-9b24-bbf077ce4050_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Expression studies using transfected CHO cells showed undetectable enzyme activity for R225H; a reduction of activity by 51% for Arg141Cys and undetectable activity for p.Ala94_Leu97del.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/36fd4390-4f3b-4adb-9b24-bbf077ce4050_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24658933","allele":{"id":"https://genegraph.clinicalgenome.org/r/fdf2e1e3-53b5-44de-9d50-58f65c194c3c"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/38edbd82-7008-4a6b-9243-7390ec4e3c98","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24658933","rdfs:label":"Patient 4a","allele":{"id":"https://genegraph.clinicalgenome.org/r/fdf2e1e3-53b5-44de-9d50-58f65c194c3c"},"detectionMethod":"ALDH7A1 normal sequencing followed by single gene test for PNPO","firstTestingMethod":"Other","phenotypes":["obo:HP_0001250","obo:HP_0001336","obo:HP_0001263","obo:HP_0000496","obo:HP_0001285","obo:HP_0000253"],"sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/36fd4390-4f3b-4adb-9b24-bbf077ce4050_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/695574c7-2506-47a6-8ca3-38b0e5a33ec2_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/036bf478-d6a0-4774-bab7-f4513b6f1692","type":"EvidenceLine","dc:description":"This variant was identified in a fetus, affected and terminated during pregnancy. Parents were carriers. Deceased sibship 6 includes a first child born at 32 weeks and died at 21 days, triplets conceived via IVF born at 24 weeks and died at 1dol and 6 months, twin brothers conceived via IVF born at 29 weeks and died at 17 and 19 days. No phenotypic information available therefore, this score has been downgraded to 0 points.","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/036bf478-d6a0-4774-bab7-f4513b6f1692_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15772097","allele":{"id":"https://genegraph.clinicalgenome.org/r/b8a531ec-ba59-4e18-8b82-10b576ec2eb3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_018129.4(PNPO):c.685C>T (p.Arg229Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA118329"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/695574c7-2506-47a6-8ca3-38b0e5a33ec2","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15772097","rdfs:label":"Patient G7","allele":{"id":"https://genegraph.clinicalgenome.org/r/b8a531ec-ba59-4e18-8b82-10b576ec2eb3"},"detectionMethod":"DNA analysis from the chorionic villus indicated that the foetus was affected","firstTestingMethod":"Other","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/036bf478-d6a0-4774-bab7-f4513b6f1692_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/3241945e-7fb5-4217-ba2c-0dad9d1d0b95_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d0e607f6-c932-44ab-b66b-bd499b1db799","type":"EvidenceLine","dc:description":"Too high frequency in gnomAD = 525 homozygotes (gnomAD v2.1.1)","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d0e607f6-c932-44ab-b66b-bd499b1db799_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24645144","allele":{"id":"https://genegraph.clinicalgenome.org/r/2e5429e0-4756-43a1-bf30-fefddb44f608","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_018129.4(PNPO):c.347G>A (p.Arg116Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA154714"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/3241945e-7fb5-4217-ba2c-0dad9d1d0b95","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24645144","rdfs:label":"Mills Patient 8","allele":{"id":"https://genegraph.clinicalgenome.org/r/2e5429e0-4756-43a1-bf30-fefddb44f608"},"detectionMethod":"DNA analysis from the chorionic villus indicated that the foetus was affected","firstTestingMethod":"Other","phenotypes":["obo:HP_0001328","obo:HP_0001250"],"sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/d0e607f6-c932-44ab-b66b-bd499b1db799_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/7cde0d76-ef44-4a5c-80cf-28246cdbce3b_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2c7c267e-0068-40fe-b76d-308e2d8da8ba","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2c7c267e-0068-40fe-b76d-308e2d8da8ba_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"D33V reduction of enzyme activity by ~55% ***R95H reduction in activity by 18% in CHO cells.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/2c7c267e-0068-40fe-b76d-308e2d8da8ba_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24645144","allele":{"id":"https://genegraph.clinicalgenome.org/r/fc68cfd3-6ee8-4bf5-8ee9-50c0f62bfa4a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_018129.4(PNPO):c.98A>T (p.Asp33Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA316580"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/7cde0d76-ef44-4a5c-80cf-28246cdbce3b","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24645144","rdfs:label":"Mills Patient 2","allele":{"id":"https://genegraph.clinicalgenome.org/r/fc68cfd3-6ee8-4bf5-8ee9-50c0f62bfa4a"},"detectionMethod":"DNA analysis from the chorionic villus indicated that the foetus was affected","firstTestingMethod":"Other","phenotypes":"obo:HP_0001250","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/2c7c267e-0068-40fe-b76d-308e2d8da8ba_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/9e71d49b-4484-4965-830f-b5f6b22603e2_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8b1dbd08-5e73-4e67-9e5d-bdbd5d9274ce","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8b1dbd08-5e73-4e67-9e5d-bdbd5d9274ce_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Expression studies using transfected CHO cells showed undetectable enzyme activity for R225H; a reduction of activity by 51% for Arg141Cys and undetectable activity for p.Ala94_Leu97del.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/8b1dbd08-5e73-4e67-9e5d-bdbd5d9274ce_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24658933","allele":{"id":"https://genegraph.clinicalgenome.org/r/fdf2e1e3-53b5-44de-9d50-58f65c194c3c"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/9e71d49b-4484-4965-830f-b5f6b22603e2","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24658933","rdfs:label":"Patient 1b","allele":{"id":"https://genegraph.clinicalgenome.org/r/fdf2e1e3-53b5-44de-9d50-58f65c194c3c"},"detectionMethod":"ALDH7A1 normal sequence followed by single gene test for PNPO","phenotypes":["obo:HP_0000496","obo:HP_0001263","obo:HP_0032816"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/8b1dbd08-5e73-4e67-9e5d-bdbd5d9274ce_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/4b5c0852-ce99-46f8-9851-768be90442cf_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d90beeef-71c0-455d-9659-23d910ce9adc","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d90beeef-71c0-455d-9659-23d910ce9adc_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"E50K reduction of enzyme activity by 20% (previously no reduction of activity in CHO cells)  ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/d90beeef-71c0-455d-9659-23d910ce9adc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24645144","allele":{"id":"https://genegraph.clinicalgenome.org/r/976920d6-a3a5-4496-be70-cc9260513aad","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_018129.4(PNPO):c.148G>A (p.Glu50Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA316546"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/4b5c0852-ce99-46f8-9851-768be90442cf","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24645144","rdfs:label":"Mills Patient 1","allele":{"id":"https://genegraph.clinicalgenome.org/r/976920d6-a3a5-4496-be70-cc9260513aad"},"detectionMethod":"DNA analysis from the chorionic villus indicated that the foetus was affected","firstTestingMethod":"Other","phenotypes":["obo:HP_0001250","obo:HP_0001263"],"sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/d90beeef-71c0-455d-9659-23d910ce9adc_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/3de28163-eca9-4eb8-84e0-b1348c582d55_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3f54c3dd-b4ce-4807-a54d-67380e997f23","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3f54c3dd-b4ce-4807-a54d-67380e997f23_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Expression studies using transfected CHO cells showed undetectable enzyme activity for R225H; a reduction of activity by 51% for Arg141Cys and undetectable activity for p.Ala94_Leu97del.Expression studies using transfected CHO cells showed a 51% reduction in enzyme activity.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/3f54c3dd-b4ce-4807-a54d-67380e997f23_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24658933","allele":{"id":"https://genegraph.clinicalgenome.org/r/fdf2e1e3-53b5-44de-9d50-58f65c194c3c"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/3de28163-eca9-4eb8-84e0-b1348c582d55","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24658933","rdfs:label":"Patient 7","allele":{"id":"https://genegraph.clinicalgenome.org/r/fdf2e1e3-53b5-44de-9d50-58f65c194c3c"},"detectionMethod":"ALDH7A1 normal sequence followed by single gene test for PNPO","firstTestingMethod":"Other","phenotypeFreeText":"seizure free over 7 months at age 6","phenotypes":["obo:HP_0000496","obo:HP_0001336"],"sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/3f54c3dd-b4ce-4807-a54d-67380e997f23_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/e4d48dcb-66a0-407d-907e-7386127729d1_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/212b546f-d4ec-479f-9a8a-0fce43dac4ed","type":"EvidenceLine","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/212b546f-d4ec-479f-9a8a-0fce43dac4ed_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28985901","allele":{"id":"https://genegraph.clinicalgenome.org/r/234ee2fd-54d0-448d-b690-d3798e8b2bff"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/e4d48dcb-66a0-407d-907e-7386127729d1","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28985901","rdfs:label":"Guerriero Patient 4","allele":{"id":"https://genegraph.clinicalgenome.org/r/234ee2fd-54d0-448d-b690-d3798e8b2bff"},"detectionMethod":"Unknown testing strategy","phenotypes":["obo:HP_0012758","obo:HP_0001250","obo:HP_0200134"],"sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/212b546f-d4ec-479f-9a8a-0fce43dac4ed_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/1178fc4c-b8fc-4dfc-a267-985e1121bbed_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/67a215e8-0a5f-44f8-8156-fbe8365921de","type":"EvidenceLine","dc:description":"Assay unknown therefore, this score has been downgraded to 0 points.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/67a215e8-0a5f-44f8-8156-fbe8365921de_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15772097","allele":{"id":"https://genegraph.clinicalgenome.org/r/976920d6-a3a5-4496-be70-cc9260513aad"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/c89b5ced-6752-4e2e-bf4a-2d5704ab4be5","type":"EvidenceLine","dc:description":"Assay unknown therefore, this score has been downgraded to 0 points.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c89b5ced-6752-4e2e-bf4a-2d5704ab4be5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15772097","allele":{"id":"https://genegraph.clinicalgenome.org/r/47dacd7a-9468-46ea-adc8-6bdee43aef7b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_018129.4(PNPO):c.364-1G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA354156"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/1178fc4c-b8fc-4dfc-a267-985e1121bbed","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15772097","rdfs:label":"Patient J2","allele":[{"id":"https://genegraph.clinicalgenome.org/r/976920d6-a3a5-4496-be70-cc9260513aad"},{"id":"https://genegraph.clinicalgenome.org/r/47dacd7a-9468-46ea-adc8-6bdee43aef7b"}],"phenotypes":["obo:HP_0003394","obo:HP_0002104","obo:HP_0000252","obo:HP_0001903","obo:HP_0001252","obo:HP_0001942","obo:HP_0002406","obo:HP_0002533","obo:HP_0002098","obo:HP_0001250","obo:HP_0010819","obo:HP_0002133","obo:HP_0012758","obo:HP_0002181","obo:HP_0025116","obo:HP_0002240"],"sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/67a215e8-0a5f-44f8-8156-fbe8365921de_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/c89b5ced-6752-4e2e-bf4a-2d5704ab4be5_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/7acfd9a7-b15b-49a8-9ed2-c0c9f1fc543f_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/66daca41-3ca1-4bef-805b-62a5585935b1","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/66daca41-3ca1-4bef-805b-62a5585935b1_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"R95H reduction in expression by 18% in CHO","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/66daca41-3ca1-4bef-805b-62a5585935b1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18485777","allele":{"id":"https://genegraph.clinicalgenome.org/r/7c0e9a47-93ba-41d2-b732-e783a912e675","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_018129.4(PNPO):c.284G>A (p.Arg95His)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/849386"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/7acfd9a7-b15b-49a8-9ed2-c0c9f1fc543f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18485777","rdfs:label":"Patient IV3","ageType":"AgeAtOnset","ageUnit":"Days","ageValue":1,"allele":{"id":"https://genegraph.clinicalgenome.org/r/7c0e9a47-93ba-41d2-b732-e783a912e675"},"detectionMethod":"PNPO targeted sequencing","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Other","phenotypes":["obo:HP_0032794","obo:HP_0000426","obo:HP_0000470","obo:HP_0002557","obo:HP_0000218"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/66daca41-3ca1-4bef-805b-62a5585935b1_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/7b995ad3-3545-4ffb-bae2-e48ce9f5b7e8_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d4726234-2fa3-4979-a2fe-8d5fb8605606","type":"EvidenceLine","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d4726234-2fa3-4979-a2fe-8d5fb8605606_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28985901","allele":{"id":"https://genegraph.clinicalgenome.org/r/234ee2fd-54d0-448d-b690-d3798e8b2bff"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/7b995ad3-3545-4ffb-bae2-e48ce9f5b7e8","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28985901","rdfs:label":"Guerriero Patient 2","allele":{"id":"https://genegraph.clinicalgenome.org/r/234ee2fd-54d0-448d-b690-d3798e8b2bff"},"detectionMethod":"Unknown testing strategy","phenotypeFreeText":"disc pallor","phenotypes":["obo:HP_0012758","obo:HP_0001250","obo:HP_0200134"],"sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/d4726234-2fa3-4979-a2fe-8d5fb8605606_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/ce459aa3-62a1-4c21-b05a-1e6c1c773eec_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/849213c0-cb06-4097-b6cd-1174297d8e2c","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/849213c0-cb06-4097-b6cd-1174297d8e2c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25296925","allele":{"id":"https://genegraph.clinicalgenome.org/r/c6daec59-e62b-4469-a7b8-74e5531d3bd7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_018129.4(PNPO):c.448_451del (p.Pro150fs)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA208971"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/ce459aa3-62a1-4c21-b05a-1e6c1c773eec","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25296925","rdfs:label":"Guerin Patient","ageType":"AgeAtReport","ageUnit":"Months","ageValue":12,"allele":{"id":"https://genegraph.clinicalgenome.org/r/c6daec59-e62b-4469-a7b8-74e5531d3bd7"},"phenotypeFreeText":"neonatal onset seizures","phenotypes":"obo:HP_0001250","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/849213c0-cb06-4097-b6cd-1174297d8e2c_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/6a20e5b6-a929-467a-bc16-1601259001c8_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2da8ede4-d634-426c-8c37-201320480d13","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2da8ede4-d634-426c-8c37-201320480d13_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24266778","allele":{"id":"https://genegraph.clinicalgenome.org/r/fdf2e1e3-53b5-44de-9d50-58f65c194c3c"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/6a20e5b6-a929-467a-bc16-1601259001c8","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24266778","rdfs:label":"Case 1","ageType":"AgeAtOnset","ageUnit":"Days","ageValue":1,"allele":{"id":"https://genegraph.clinicalgenome.org/r/fdf2e1e3-53b5-44de-9d50-58f65c194c3c"},"detectionMethod":"SNP array followed by single gene test for PNPO","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Other","phenotypes":["obo:HP_0001336","obo:HP_0000496"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/2da8ede4-d634-426c-8c37-201320480d13_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/9c7b6724-bb8c-43f5-a84e-df952858d522_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9ac6f151-3d32-4d6c-90d8-da0eecbc88ca","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9ac6f151-3d32-4d6c-90d8-da0eecbc88ca_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"D33V reduction of enzyme activity by ~55%.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/9ac6f151-3d32-4d6c-90d8-da0eecbc88ca_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24645144","allele":{"id":"https://genegraph.clinicalgenome.org/r/fc68cfd3-6ee8-4bf5-8ee9-50c0f62bfa4a"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/9c7b6724-bb8c-43f5-a84e-df952858d522","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24645144","rdfs:label":"Mills Patient 9","allele":{"id":"https://genegraph.clinicalgenome.org/r/fc68cfd3-6ee8-4bf5-8ee9-50c0f62bfa4a"},"detectionMethod":"DNA analysis from the chorionic villus indicated that the foetus was affected","firstTestingMethod":"Other","phenotypeFreeText":"minimal delay","phenotypes":"obo:HP_0001250","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/9ac6f151-3d32-4d6c-90d8-da0eecbc88ca_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/881e719a-4ef0-4316-82b8-05a70b16aab2_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/901997f2-cb3f-4aaf-8df9-1ca4b3347c76","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/901997f2-cb3f-4aaf-8df9-1ca4b3347c76_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Expression studies using transfected CHO cells showed undetectable enzyme activity for R225H; a reduction of activity by 51% for Arg141Cys and undetectable activity for p.Ala94_Leu97del.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/901997f2-cb3f-4aaf-8df9-1ca4b3347c76_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24658933","allele":{"id":"https://genegraph.clinicalgenome.org/r/fdf2e1e3-53b5-44de-9d50-58f65c194c3c"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/881e719a-4ef0-4316-82b8-05a70b16aab2","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24658933","rdfs:label":"Patient 2b","allele":{"id":"https://genegraph.clinicalgenome.org/r/fdf2e1e3-53b5-44de-9d50-58f65c194c3c"},"detectionMethod":"ALDH7A1 normal sequence followed by single gene test for PNPO","firstTestingMethod":"Other","phenotypeFreeText":"desaturation, recurrent single breakthrough seizure during infancy","phenotypes":["obo:HP_0000496","obo:HP_0002133","obo:HP_0001336","obo:HP_0001263"],"sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/901997f2-cb3f-4aaf-8df9-1ca4b3347c76_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/7dd90074-4ee0-474a-952a-f626686e3037_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e6193f7c-0677-4568-8166-9332dfbf75fa","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e6193f7c-0677-4568-8166-9332dfbf75fa_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"**Expression studies using transfected CHO cells showed undetectable enzyme activity for R225H; a reduction of activity by 51% for Arg141Cys and undetectable activity for p.Ala94_Leu97del.Expression studies using transfected CHO cells showed a 51% reduction in enzyme activity.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/e6193f7c-0677-4568-8166-9332dfbf75fa_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24658933","allele":{"id":"https://genegraph.clinicalgenome.org/r/fdf2e1e3-53b5-44de-9d50-58f65c194c3c"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/7dd90074-4ee0-474a-952a-f626686e3037","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24658933","rdfs:label":"Patient 6","allele":{"id":"https://genegraph.clinicalgenome.org/r/fdf2e1e3-53b5-44de-9d50-58f65c194c3c"},"detectionMethod":"ALDH7A1 normal sequence followed by single gene test for PNPO","firstTestingMethod":"Other","phenotypeFreeText":"cognitive deficit","phenotypes":["obo:HP_0000496","obo:HP_0001336","obo:HP_0001285","obo:HP_0005484"],"sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/e6193f7c-0677-4568-8166-9332dfbf75fa_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/2274155d-b5aa-44af-bc38-0a329f721ff9_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/92067ba3-1aaf-46a4-b3b2-f4469d3da9c7","type":"EvidenceLine","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/92067ba3-1aaf-46a4-b3b2-f4469d3da9c7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28133863","allele":{"id":"https://genegraph.clinicalgenome.org/r/778540fe-d8c9-4040-827f-d01dd813d406"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/2274155d-b5aa-44af-bc38-0a329f721ff9","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28133863","rdfs:label":"Patient 18","allele":{"id":"https://genegraph.clinicalgenome.org/r/778540fe-d8c9-4040-827f-d01dd813d406"},"detectionMethod":"clinical gene panel","firstTestingMethod":"PCR","phenotypes":["obo:HP_0002487","obo:HP_0000580","obo:HP_0032833","obo:HP_0001252","obo:HP_0002266","obo:HP_0010851"],"sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/92067ba3-1aaf-46a4-b3b2-f4469d3da9c7_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":3593,"specifiedBy":"GeneValidityCriteria8","strengthScore":14,"subject":{"id":"https://genegraph.clinicalgenome.org/r/NgWUc1HUq0s","type":"GeneValidityProposition","disease":"obo:MONDO_0012407","gene":"hgnc:30260","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_f3ff7b38-dd26-458a-afbb-4870785c42ec-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}